Dennis Matheis, Director at Lucid Diagnostics Inc. (LUCD), bought 245,000 shares at $1.00 ($245K) on 2026-05-20, disclosed to the SEC on 2026-05-21.
Open-market purchase of $245k LUCD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| LUCD | BUY | 2025-05-23 | $873K | — | Filing → |